halocynthiaxanthin and Colonic-Neoplasms

halocynthiaxanthin has been researched along with Colonic-Neoplasms* in 2 studies

Other Studies

2 other study(ies) available for halocynthiaxanthin and Colonic-Neoplasms

ArticleYear
Halocynthiaxanthin and peridinin sensitize colon cancer cell lines to tumor necrosis factor-related apoptosis-inducing ligand.
    Molecular cancer research : MCR, 2007, Volume: 5, Issue:6

    Carotenoids are compounds contained in foods and possess anticarcinogenic activity. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a promising candidate for cancer therapeutics due to its ability to induce apoptosis selectively in cancer cells. However, some tumors remain tolerant to TRAIL-induced apoptosis. Therefore, it is important to develop agents that overcome this resistance. We show, for the first time, that certain carotenoids sensitize cancer cells to TRAIL-induced apoptosis. Combined treatment with halocynthiaxanthin, a dietary carotenoid contained in oysters and sea squirts, and TRAIL drastically induced apoptosis in colon cancer DLD-1 cells, whereas each agent alone only slightly induced apoptosis. The combination induced nuclear condensation and poly(ADP-ribose) polymerase cleavage, which are major features of apoptosis. Various caspase inhibitors could attenuate the apoptosis induced by this combination. Furthermore, the dominant-negative form of a TRAIL receptor could block the apoptosis, suggesting that halocynthiaxanthin specifically facilitated the TRAIL signaling pathway. To examine the molecular mechanism of the synergistic effect of the combined treatment, we did an RNase protection assay. Halocynthiaxanthin markedly up-regulated a TRAIL receptor, death receptor 5 (DR5), among the death receptor-related genes, suggesting a possible mechanism for the combined effects. Moreover, we examined whether other carotenoids also possess the same effects. Peridinin, but not alloxanthin, diadinochrome, and pyrrhoxanthin, induced DR5 expression and sensitized DLD-1 cells to TRAIL-induced apoptosis. These results indicate that the combination of certain carotenoids and TRAIL is a new strategy to overcome TRAIL resistance in cancer cells.

    Topics: 4-Butyrolactone; Apoptosis; Carotenoids; Caspase Inhibitors; Cell Line, Tumor; Colonic Neoplasms; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Poly(ADP-ribose) Polymerases; Signal Transduction; TNF-Related Apoptosis-Inducing Ligand; Xanthophylls

2007
Anti-neoplastic effect of halocynthiaxanthin, a metabolite of fucoxanthin.
    Anti-cancer drugs, 1992, Volume: 3, Issue:5

    We have reported that fucoxanthin, a natural carotenoid, inhibited the growth of human neuroblastoma GOTO cells. In the present study, we show that a metabolite of fucoxanthin, halocynthiaxanthin, which is isolated from sea squirt Halocynthia roretzi, has a more potent inhibitory effect. Halocynthiaxanthin (5 micrograms/ml) caused complete suppression of GOTO cell proliferation, whereas fucoxanthin reduced the growth rate by only 88.8% compared with the control, at day 2 after the drug treatment. Furthermore, halocynthiaxanthin also inhibited the growth of other human malignant tumor cells. Thus halocynthiaxanthin seems to be a promising anti-neoplastic agent.

    Topics: Antineoplastic Agents; Carotenoids; Cell Division; Colonic Neoplasms; DNA, Neoplasm; Food; Gene Expression; Genes, myc; HeLa Cells; Humans; Kinetics; Neoplasm Proteins; Neuroblastoma; Pancreatic Neoplasms; RNA, Neoplasm; Stomach Neoplasms; Tumor Cells, Cultured; Xanthophylls

1992
chemdatabank.com